LG Life Sciences Ltd. Pfd. Series 1 | Income Statement
Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
23,143,612
22,577,830
20,206,583
20,659,296
25,698,014
Cost of Goods Sold (COGS) incl. D&A
19,869,212
19,622,359
16,597,227
16,721,559
20,305,925
Gross Income
3,274,400
2,955,471
3,609,356
3,937,737
5,392,089
SG&A Expense
1,531,356
1,644,710
1,785,788
1,945,817
2,463,632
EBIT
1,743,044
1,310,761
1,823,568
1,991,920
2,928,457
Unusual Expense
76,923
82,417
202,599
57,359
142,398
Non Operating Income/Expense
40,707
54,338
61,786
234,303
159,123
Interest Expense
65,239
79,175
58,069
76,913
99,877
Pretax Income
1,601,296
1,159,861
1,549,643
1,659,828
2,563,895
Income Tax
330,683
305,836
401,112
378,834
541,922
Consolidated Net Income
1,270,613
854,025
1,148,531
1,280,994
2,021,973
Net Income
1,265,968
867,924
1,152,987
1,281,124
1,945,280
Net Income After Extraordinaries
1,265,968
867,924
1,152,987
1,281,124
1,945,280
Net Income Available to Common
1,265,968
867,924
1,152,987
1,281,124
1,945,280
EPS (Basic)
17,216.00
11,803.00
15,679.00
17,422.00
25,391.00
Basic Shares Outstanding
74
74
74
74
77
EPS (Diluted)
17,215.92
11,802.92
15,679.49
17,422.03
25,391.08
Diluted Shares Outstanding
74
74
74
74
77
EBITDA
2,788,460
2,461,218
3,079,650
3,328,613
4,334,082
Non-Operating Interest Income
35,733
45,463
37,516
40,274
30,216
Minority Interest Expense
4,645
13,899
4,456
130
76,693
Equity in Affiliates (Pretax)
5,388
19,567
11,013
3,791
6,620
About LG Life Sciences
View Profile
